Silver Book Fact

High-intensity ultrasonic cyclocoagulation reduces intraocular pressure in refractory glaucoma patients.

Aptel F, Charrell T, Lafon C, Ramano F, et al. Miniaturized High-Intensity Focused Ultrasound Device in Patients with Glaucoma: A clinical pilot study. Invest Opthalmol Vis Sci. 2011; 52(12): 8747-8753. http://iovs.arvojournals.org/article.aspx?articleid=2187000

Reference

Title
Miniaturized High-Intensity Focused Ultrasound Device in Patients with Glaucoma: A clinical pilot study
Publication
Invest Opthalmol Vis Sci
Publication Date
2011
Authors
Aptel F, Charrell T, Lafon C, Ramano F, et al
Volume & Issue
Volume 52, Issue 12
Pages
8747-8753
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • DR Treatment Savings in the US
    Every year, the U.S. saves an estimated $1.6 billion by treating DR.  
  • Supplementation with lutein increases macular pigment optical density by 27%; which is correlated with benefits in visual function.  
  • Screening and treatment for eye disease in all type 2 diabetes patients would result in an estimated net savings of over $472.1 million– in 1994 dollars.  
  • Timely treatment and follow-up care can reduce the risk of blindness in individuals with proliferative retinopathy by 95%.  
  • Detection and treatment of proliferative diabetic eye disease and clincally significant macular edema with laser therapy can reduce severe vision loss progression by 50% to 60%